Net Daş-Evcimen
Impact in
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
-
- Natural Antidiabetic Agents Studies
Papers in
-
- Aldose Reductase and Taurine 9
-
- Diet, Metabolism, and Disease 3
- Natural Antidiabetic Agents Studies 3
- Co-authors
- Gerard King (1 shared paper)Oya Bozdağ‐Dündar (4 shared papers)Rahmiye Ertan (3 shared papers)Milan Štefek (2 shared papers)Çi̇men Karasu (2 shared papers)Fügen Aktan (2 shared papers)Svorad Štolc (2 shared papers)Nuriye Nuray Ulusu (2 shared papers)
- Journals
- Medicinal Chemistry Research (3 papers)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (1 paper)Journal of Enzyme Inhibition and Medicinal Chemistry (1 paper)European Journal of Medicinal Chemistry (1 paper)Pharmacological Research (1 paper)
- Partner nations
- TürkiyeUnited StatesGermany
In The Last Decade
Net Daş-Evcimen
15 papers receiving 612 citations
Peers
Comparison fields: 5 of 80
- Clinical Biochemistry 90
- Endocrinology, Diabetes and Metabolism 117
- Ophthalmology 59
- Biochemistry 34
- Cell Biology 74
Countries citing papers authored by Net Daş-Evcimen
This map shows the geographic impact of Net Daş-Evcimen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Net Daş-Evcimen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Net Daş-Evcimen more than expected).
Fields of papers citing papers by Net Daş-Evcimen
This network shows the impact of papers produced by Net Daş-Evcimen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Net Daş-Evcimen. The network helps show where Net Daş-Evcimen may publish in the future.
Co-authors
The 24 scholars most cited alongside Net Daş-Evcimen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 390 | |
| 2 | 2002 | 66 | |
| 3 | 2008 | 43 | |
| 4 | 2008 | 34 | |
| 5 | In vivo treatment with stobadine prevents lipid peroxidation, protein glycation and calcium overload but does not ameliorate Ca 2+ -ATPase activity in heart and liver of streptozotocin-diabetic rats: comparison with vitamin E The ADIC (Antioxidants in Diabetes-Induced Complications) Study Group | 2002 | 23 |
| 6 | 2017 | 17 | |
| 7 | 2007 | 15 | |
| 8 | 2008 | 10 | |
| 9 | 2010 | 8 | |
| 10 | 2018 | 7 | |
| 11 | 2009 | 7 | |
| 12 | 2015 | 6 | |
| 13 | 2007 | 5 | |
| 14 | 2013 | 4 | |
| 15 | 2010 | 1 |
About Net Daş-Evcimen
Net Daş-Evcimen is a scholar working on Cell Biology, Endocrinology, Diabetes and Metabolism, Molecular Biology, Physiology and Pharmacology, having authored 15 papers that have together received 636 indexed citations. Recurring topics across this work include Aldose Reductase and Taurine (9 papers), Polyamine Metabolism and Applications (4 papers), Biochemical effects in animals (3 papers), Diet, Metabolism, and Disease (3 papers), Natural Antidiabetic Agents Studies (3 papers), Cannabis and Cannabinoid Research (3 papers), Phytochemicals and Antioxidant Activities (2 papers) and Chronic Kidney Disease and Diabetes (2 papers). The work is most often cited by research in Clinical Biochemistry (90 citations), Endocrinology, Diabetes and Metabolism (117 citations), Ophthalmology (59 citations), Biochemistry (34 citations) and Cell Biology (74 citations). Net Daş-Evcimen has collaborated with scholars based in Türkiye, United States and Germany. Frequent co-authors include Gerard King, Oya Bozdağ‐Dündar, Rahmiye Ertan, Milan Štefek, Çi̇men Karasu, Fügen Aktan, Svorad Štolc, Nuriye Nuray Ulusu, Síbel Süzen and Katrin Bauer. Their work appears in journals such as Medicinal Chemistry Research, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Journal of Enzyme Inhibition and Medicinal Chemistry, European Journal of Medicinal Chemistry and Pharmacological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.